15 completed. 15 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 15 | Completed 15 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU Patients Real-time AI-assisted muscle ultrasound - Tetanus | Not applicable | Completed | Oxford University Clinical Research Unit, Vietnam | 254 | 2020-06-01 | 2024-03-20 |
| Adapting Motivational Interviewing for Maternal Immunizations (MI4MI) Prevention, Maternal Immunization - Maternal Immunization | Not applicable | Completed | University of Colorado, Denver | 1350 | 2020-05-27 | 2023-05-12 |
| Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Modified clinical reminders - Influenza, Tetanus | Not applicable | Completed | Atlanta VA Medical Center | 67000 | 2018-10-15 | 2020-01-10 |
| Evaluation of an Infant Immunization Encouragement Program in Nigeria All Babies Are Equal Initiative (conditional cash transfer program) - Tuberculosis, Diphtheria | Not applicable | Completed | GiveWell | 5187 | 2018-07-01 | 2020-03-31 |
| The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval - Diphtheria, Tetanus | Not applicable | Completed | Vabiotech | 222 | 2018-03-01 | 2019-05-03 |
| Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda SMS text reminders - Diphtheria, Tetanus | Not applicable | Completed | Centers for Disease Control and Prevention | 1962 | 2016-02-01 | 2019-11-26 |
| The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine - Rotavirus Infections, Intestinal Bacteria Flora Disturbance | Not applicable | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 63 | 2015-09-01 | 2017-07-25 |
| Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya SMS reminder, Travel subsidy, Travel subsidy 2 - Diphtheria, Tetanus | Not applicable | Completed | Johns Hopkins Bloomberg School of Public Health | 2018 | 2013-10-01 | 2022-10-27 |
| Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain Tetanus toxoid vaccine - Tetanus, Tetanus Vaccine | Not applicable | Completed | Epicentre | 2129 | 2012-11-01 | 2013-05-03 |
| Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function retinyl palmitate, Placebo - Vitamin A Deficiency | Not applicable | Completed | USDA, Western Human Nutrition Research Center | 300 | 2012-01-01 | 2014-08-26 |
| Pneumonia in Tetanus Study semi-recumbent, supine - Tetanus | Not applicable | Completed | Oxford University Clinical Research Unit, Vietnam | 200 | 2000-08-01 | 2011-09-15 |
| The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV Tetanus toxoid, Hepatitis A Vaccine (Inactivated) - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 81 | 2000-02-01 | 2013-10-07 |
| Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV Tetanus Toxoid Vaccine, Indinavir sulfate, Lamivudine/Zidovudine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 288 | 1999-10-01 | 2011-03-02 |
| A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART Thalidomide - HIV Infections | Not applicable | Completed | Rockefeller University | 12 | 2005-06-24 | |
| Effect of Interleukin-2 on HIV Treatment Interruption Aldesleukin - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 2021-11-01 |
Diphtheria (6) · Hepatitis B (6) · Whooping Cough (6) · HIV Infections (4) · Haemophilus Infections (4) · Measles (3) · Influenza, Human (2) · Pneumonia (2) · Poliomyelitis (2) · Rotavirus Infections (2) · Tuberculosis (2) · Hepatitis (1) · Malnutrition (1) · Muscular Atrophy (1)
Bacterial Infections (15) · Bacterial Infections and Mycoses (15) · Clostridium Infections (15) · Gram-Positive Bacterial Infections (15) · Infections (15) · Virus Diseases (12) · RNA Virus Infections (10) · Blood-Borne Infections (9) · Communicable Diseases (9) · Actinomycetales Infections (7) · Digestive System Diseases (7) · Liver Diseases (7) · Respiratory Tract Diseases (7) · Respiratory Tract Infections (7) · Bordetella Infections (6)
Tetanus Toxoid (4) · Hepatitis A Vaccines (1) · Hepatitis B Vaccines (1) · Indinavir (1) · Lamivudine (1) · Pneumococcal Vaccines (1) · Ritonavir (1) · Rotavirus Vaccines (1) · Supine Position (1) · Thalidomide (1) · Vitamin A (1) · Zidovudine (1) · abacavir (1) · aldesleukin (1) · amprenavir (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Oxford University Clinical Research Unit, Vietnam (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Atlanta VA Medical Center (1) · Centers for Disease Control and Prevention (1) · Epicentre (1) · GiveWell (1) · Johns Hopkins Bloomberg School of Public Health (1) · Rockefeller University (1) · USDA, Western Human Nutrition Research Center (1) · University of Colorado, Denver (1) · Vabiotech (1)
United States (6) · Vietnam (2) · Australia (1) · Bangladesh (1) · Chad (1) · Kenya (1) · Netherlands (1) · Nigeria (1) · Puerto Rico (1)
Aitana Juan Giner, MSc (1) · Alison Connor, PhD (1) · Charles B. Stephensen, Ph.D. (1) · Christopher Parry, MD (1) · Daniel C Ehlman, MPH (1) · Joseph M Wallace (1) · Lawrence Corey (1) · Mona Rigaud, MD, MPH (1) · Pompa Debroy, MS (1) · Russ Burnett, PhD (1) · Saad Omer, MBBS, MPH, PhD (1) · Sean O'Leary, MD, MPH (1) · Sophie Yacoub, PhD (1) · Vincent Marconi, MD (1) · W. Keith Henry, MD (1)
PMID 16760795, PMID 16816555, PMID 18431498, PMID 18752430, PMID 22197012, PMID 25269669, PMID 28288747, PMID 30674610, PMID 31504694, PMID 32939553, PMID 33625372, PMID 36227309
R21AI141822 (1)